Sign in

CIK 0000943819

  • Large accelerated filer
Tickers
RMD RSMDF
Exchange
NYSE, OTC
Industry
Surgical & Medical Instruments & Apparatus
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
980152841
Phone
+1 858-746-2400
Business address
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123

Securities

  • RMD ResMed Inc. Common Stock NYSE
  • RSMDF Common stock OTC
  1. 4 Planned sale Chief Financial Officer sold 1,000 shares at $230.36 ($230,360)
  2. 4 Planned sale Chief Commercial Officer, SaaS sold 9,745 shares at $239.31 ($2,332,096)
  3. 4 Planned sale Chief Executive Officer sold 8,009 shares at $229.20 ($1,835,692)
  4. 4 Planned sale Director sold 2,000 shares at $227.71 ($455,420)
  5. 4 Planned sale Chief Commercial Officer, SaaS sold 9,113 shares at an average $235.40 ($2,145,186)
  6. 4 Planned sale Global General Counsel sold 64 shares at $234.10 ($14,982)
  7. 4 Planned sale Chief Financial Officer sold 1,000 shares at $238.98 ($238,980)
  8. 4 Planned sale Chief Executive Officer sold 8,009 shares at $236.77 ($1,896,307)
  9. 4 Planned sale Director sold 2,000 shares at $242.11 ($484,220)
  10. 4 Planned sale Global General Counsel sold 64 shares at $242.42 ($15,515)
  11. 4 Planned sale Chief Financial Officer sold 1,000 shares at $234.04 ($234,040)
  12. 4 Planned sale Director sold 2,000 shares at $230.99 ($461,980)
  13. 4 Planned sale Global General Counsel sold 75 shares at $230.99 ($17,324)
  14. 4 Planned sale Chief Financial Officer sold 1,000 shares at $244.23 ($244,230)
  15. 4 Planned sale Director sold 2,000 shares at $245.65 ($491,300)
  16. 4 Planned sale Global General Counsel sold 74 shares at $248.91 ($18,419)
  17. 4 Open-market sale Chief Executive Officer sold 2,000 shares at $249.67 ($499,330)
  18. 4 Derivatives Options or other derivatives
  19. 4 Open-market sale Chief Product Officer sold 6,160 shares at $243.09 ($1,497,416)
  20. 4 Grant or award Director acquired 1,083 shares (grant or award)

Page 6 of 92 · 1,833 filings